Marion Campbell Profile picture
Jun 5, 2023 8 tweets 4 min read Read on X
I have spoken about the importance of minimally clinically important differences (#MCID)
before in relation to sample sizes but how do you decide what it should be? There was an interesting paper published this week adding to this literature 1/8
#MethodologyMonday
The MCID drives the sample size - it is the minimum clinically important difference you set your trial to detect. Set the MCID too small and the sample size will be much larger than needed; but make the MCID too big & your trial will miss clinically important effects 2/8
There are different methods of calculating #MCIDs - the DELTA project is a great resource in this regard. 3/8
DELTA: journalslibrary.nihr.ac.uk/hta/hta18280/#… Image
DELTA identified seven main methods for calculating MCIDs - anchor, distribution, health economic, opinion-seeking, pilot study, review of evidence base and standardised effect sizes. 4/8 Image
The DELTA team also published a guide on how to choose an appropriate MCID (in the DELTA-2 project) 5/8
bmj.com/content/363/bm… Image
This week, Wang et al also published a useful framework to help guide which MCID to use (this one focussing on patient reported outcomes) especially if there are a selection of different possible MCID estimates available. 6/8
bmj.com/content/381/bm… Image
The framework proposes a systematic step-by-step action plan to ensure the choice of MCID is both methodologically sound and contextually relevant. They provide a detailed flow chart to navigate the process 7/8 Image
Repeated studies have found that the choice of MCID is often not defined or justified in trial protocols or reports. As with most other aspects of trials, reporting needs to be better 8/8

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Marion Campbell

Marion Campbell Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MarionKCampbell

May 13
A popular, but often misused design, is the #Crossover trial design. But what are the key things to look out for if you are considering using it? 1/9 #MethodologyMonday #87
In a crossover trial each participant receives two (or more) treatments in a random order. The most common design is an AB/BA design (2 treatment, 2 period design) which randomises half the sample to receive treatment A first then B and the other half to B first then A. 2/9
Because each person acts as their own control this removes a large element of variation, making the design more powerful than a standard parallel group study 3/9
Read 9 tweets
Mar 25
In clinical trials, we sometimes undertake #SensitivityAnalysis alongside the main primary analysis. But when should we use them and to what purpose? 1/8
#MethodologyMonday #80
Sensitivity analyses can assess the impact of key elements/assumptions of a trial on the result eg impact of any baseline imbalance, impact of the choice of analysis approach etc 2/8
If the different sensitivity analyses provide similar results one is reassured that the trial result is robust and thus the credibility of the trial findings are increased 3/8
Read 8 tweets
Mar 4
I have spoken about “usual care” or “treatment as usual” as a control arm in trials before, but should you ever protocolise usual care or just measure it as is? 1/8
#MethodologyMonday #77
Whilst “usual care” implies a common package of care being applied across sites, there is often a high degree of heterogeneity in care provided - but many would argue that the heterogeneity will increase the external validity of the trial results 2/8
However, heterogeneity in the usual care control group may affect the internal validity of the trial. It can affect the effect size and can make the trial result hard to interpret. 3/8
Read 8 tweets
May 29, 2023
While 1:1 randomisation to interventions is most common in clinical trials, sometimes #UnequalRandomisation is used. There are a number of factors that influence which randomisation ratio to use 1/9
#MethodologyMonday
One justification for unequal randomisation is when there is a substantial difference in cost of treatments. In this scenario, randomising unequally with fewer to the very expensive arm maximises efficiency when a trial has set resources 2/9
bmj.com/content/321/72… Image
Another is if you are undertaking an early investigation of a new treatment and need to have greater insights into its underlying safety/benefit profile. Here, increasing allocation to the new treatment will provide greater precision around these estimates 3/9
Read 9 tweets
Apr 24, 2023
One phenomenon that can affect clinical trials is the #HawthorneEffect. This is when purely being involved in a trial can improve performance. 1/9
#MethodologyMonday
The #HawthorneEffect was named after a famous set of experiments at the Hawthorne Western Electric plant, Illinois in the 1920/30s. 2/9
In one experiment lighting levels were repeatedly changed & with each change, productivity increased .. even when reverting to poorer lighting. This was attributed to workers knowing their work was being observed. Productivity returned to normal after the experiments ended 3/9
Read 9 tweets
Apr 17, 2023
This week some of my discussions have centred on #ClusterTrials. Cluster trials involve the randomisation of intact units (wards, hospitals, GP practices etc) rather than individuals. They have a number of key elements that must be accounted for 1/11
#MethodologyMonday
There are very good reasons for cluster/group randomisation eg when evaluating interventions like clinical guidelines or educational interventions which apply at practice/hospital level; or when there is potential of contamination of the intervention across trial groups 2/11
However, cluster randomisation has some major impacts for design & analysis primarily because observations within a cluster are not independent (outcomes are likely to be more similar within a cluster) 3/11
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(